Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients

23 Apr 2019

Abstract excerpt

// Elena Castellanos-Rizaldos 1 , * , Xuan Zhang 1 , * , Vasisht R. Tadigotla 1 , Dominik G. Grimm 2 , Chris Karlovich 3 , Luis E. Raez 4 and Johan K. Skog 1 1 Exosome Diagnostics, a Bio-Techne brand, Waltham, Massachusetts, USA 2 Exosome Diagnostics, a Bio-Techne brand, Martinsried, Germany 3 Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA 4 Memorial Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31080561
DOI: 10.18632/oncotarget.26885

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patientsPMID 31080561Read ↗

Exosome-Based Detection of EGFR T790M in Plasma from Non-Small Cell Lung Cancer Patients.Semantic proximity Read ↗

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Semantic proximity Read ↗

Assessing the Sensitivity of Nested PCR Followed by Direct Sequencing on Exosomal DNA for EGFR Mutation Detection in NSCLSemantic proximity Read ↗

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patientsSemantic proximity Read ↗

Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients.Semantic proximity Read ↗

Detection of EGFR Mutations Using Bronchial Washing-Derived Extracellular Vesicles in Patients with Non-Small-Cell Lung CarcinomaSemantic proximity Read ↗

ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung CancerSemantic proximity Read ↗

Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.Semantic proximity Read ↗

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasmaSemantic proximity Read ↗

Liquid Biopsy for EGFR Mutation Detection in NSCLC: Evaluation of Plasma ctDNA and Comparison with Plasma exoDNA.Semantic proximity Read ↗

Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients.Semantic proximity Read ↗

Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.